2006 Faculty Awards: Boyce Wins Established Entrepreneur Award
Burn patients and others with chronic skin wounds will benefit from a new medical product developed by Steven Boyce.
Dr. Boyce developed a cultured skin substitute, tradenamed PermaDerm, which allows damaged skin to regenerate with the use of less donated skin, thus reducing the need for skin grafts from other parts of the patients body.
PermaDerm combines a biodegradeable fabric made from collagen with the patients skin cells in a graft that allows skin to regrow. One advantage to his discovery is that it has been used successfully with large burns even patients who suffer burns over as much as 90 percent of their bodies.
Boyce holds six U.S. patents in tissue engineering and recently sold his start-up company, Cutanogen, to Cambrex Corporation. Boyce has served on the UC faculty since 1989.
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
UC’s microchip training includes innovative VR
July 2, 2024
To build a virtual microchip factory, University of Cincinnati doctoral students turned to the real one where they work. UC launched a new training program for microchip manufacturing in advance of the new fabrication plant Intel Corp. is opening in Ohio.
Cincinnati researchers want to know if MRIs can work better
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.